EVP Strategy and Innovation of Myriad Genetics Inc (NASDAQ:MYGN), Parkinson Paul, sells 11,824 shares worth $295,600

According to Myriad Genetics Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 04:40 PM, company EVP Strategy and Innovation, Parkinson Paul disclosed selling 11,824 shares at a cost of $25.00. At the time of this transaction (Jan 08), this trade was worth $295,600 in total. As of Jan 08, Parkinson Paul now owns 76,746 shares in total worth about $1,952,418.24.

For the last few recent trades made by Myriad Genetics Inc (NASDAQ:MYGN) EVP Strategy and Innovation, Parkinson Paul, we have the following information:

Posted by George Daniels on Monday January 11 2021, 9:16 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0